Immunotherapy for cancer.

It seems nonetheless reasonable to take a skeptical view of immunotherapy for cancer. If the immunologic response can be brought to bear meaningfully and effectively upon the tumorhost relationship so that the host is spared, then let it be proved by appropriate clinical trials. Without unrealistic expectations, it may be easier to tolerance the gradual realization that immunotherapy may be only peripherally important in the control of malignant disease.